Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net income including noncontrolling interests	$ 291,018	$ 182,788
Loss from discontinued operations	0	3,448
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:
Depreciation and amortization	62,429	50,220
Share-based compensation expense related to equity classified awards	23,910	21,569
Amortization and write-off of program rights	525,609	458,176
Amortization of deferred carriage fees	12,013	8,148
Unrealized foreign currency transaction loss	5,739	14,997
Unrealized loss (gain) on derivative contracts, net	1,355	(2,417)
Amortization of deferred financing costs and discounts on indebtedness	6,743	6,436
Bad debt expense	2,151	2,357
Deferred income taxes	(9,849)	(23,926)
Excess tax benefits from share-based compensation arrangements	(4,297)	(5,662)
Other, net	(2,073)	(2,113)
Changes in assets and liabilities:
Accounts receivable, trade	6,155	7,712
Amounts due from related parties, net	69	3,301
Prepaid expenses and other assets	(43,665)	600
Program rights and obligations, net	(616,047)	(510,384)
Income taxes payable	16,107	18,553
Deferred revenue	15,446	16,219
Deferred carriage fees, net	(18,825)	(13,234)
Accounts payable, accrued expenses and other liabilities	26,985	25,042
Net cash provided by operating activities	300,973	261,830
Cash flows from investing activities:
Capital expenditures	(48,810)	(24,340)
Payments for acquisition of a business, net of cash acquired	(6,545)	(1,024,427)
Purchases of investments	(24,250)	(3,984)
Proceeds from insurance settlements	0	654
Net cash used in investing activities	(79,605)	(1,052,097)
Cash flows from financing activities:
Proceeds from the issuance of long-term debt	0	600,000
Principal payments on long-term debt	(55,500)	0
Payment of Promissory Note	(40,000)	0
Payments for financing costs	0	(9,266)
Deemed repurchases of restricted stock/units	(14,454)	(17,804)
Proceeds from stock option exercises	1,183	1,070
Excess tax benefits from share-based compensation arrangements	4,297	5,662
Principal payments on capital lease obligations	(2,392)	(2,707)
Distributions to noncontrolling interest	(3,154)	0
Contributions from noncontrolling interest	1,354	835
Net cash (used in) provided by financing activities	(108,666)	577,790
Net increase (decrease) in cash and cash equivalents from continuing operations	112,702	(212,477)
Cash flows from discontinued operations
Net cash used in operating activities	0	(2,955)
Net decrease in cash and cash equivalents from discontinued operations	0	(2,955)
Effect of exchange rate changes on cash and cash equivalents	(6,514)	(9,897)
Cash and cash equivalents at beginning of period	201,367	521,951
Cash and cash equivalents at end of period	$ 307,555	$ 296,622